Description
Pertuzumab y Trastuzumab
Vía de administración: Intraarticular (IA)
Tratamiento de la enfermedad de Hurler-Scheie o MPS I
AFINITOR® 5 mg es un medicamento oncológico de Novartis formulado con everolimus como principio activo
SELTZ CALCIO+D S ALI 20 TAB EFER NEOMICINA 0.35 G DEXAMETASONA 0.90 MG Pertuzumab y TrastuzumabPRINCIPIO ACTIVO: SUPLEMENTO ALIMENTICIO
Exchange/Return Notes
- We offer a 30-day return/exchange service after receiving.
- Final sale items are not eligible for returns or exchanges.
- To process your return/exchange, please contact us at [email protected]
- Please click here for more details>>> Return & Exchange Policy
You may also like
recommand products
